Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SPILF update on bacterial arthritis in adults and children.
Stahl JP, Canouï E, Pavese P, Bleibtreu A, Dubée V, Ferry T, Gillet Y, Lemaignen A, Lorrot M, Lourtet-Hascoët J, Manaquin R, Meyssonnier V, Pham TT, Varon E, Lesprit P, Gauzit R; reviewers. Stahl JP, et al. Among authors: lemaignen a. Infect Dis Now. 2023 Jun;53(4):104694. doi: 10.1016/j.idnow.2023.104694. Epub 2023 Mar 21. Infect Dis Now. 2023. PMID: 36948248
Enterococcus faecalis endocarditis risk assessment in patients with bacteremia: External validation of the DENOVA score.
Danneels P, Chabrun F, Picard L, Martinet P, Rezig S, Lorleac'h A, Buzelé R, Beaudron A, Kempf M, Le Moal G, Revest M, Boutoille D, Lemaignen A, Grandiere-Perez L, Nacher M, Dubée V. Danneels P, et al. Among authors: lemaignen a. J Infect. 2023 Dec;87(6):571-573. doi: 10.1016/j.jinf.2023.09.001. Epub 2023 Sep 6. J Infect. 2023. PMID: 37683897 Free article. No abstract available.
Linezolid-related adverse events predictive score (LAPS): Usefulness in clinical practice.
Buzelé R, Lemaignen A, Pourrat X, Rosset P, Gras G, Druon J, Bernard MC, Sautenet B, Bastides F, Bernard L. Buzelé R, et al. Among authors: lemaignen a. Int J Antimicrob Agents. 2015 Dec;46(6):727-8. doi: 10.1016/j.ijantimicag.2015.09.002. Epub 2015 Sep 30. Int J Antimicrob Agents. 2015. PMID: 26526894 No abstract available.
[Is MRI useful in the follow-up of pyogenic vertebral osteomyelitis?].
Benhamou M, Lemaignen A, Ghout I, Saint-Hilaire A, Dinh A, Cottier JP, Bernard L. Benhamou M, et al. Among authors: lemaignen a. Presse Med. 2017 May;46(5):468-471. doi: 10.1016/j.lpm.2017.03.020. Epub 2017 Apr 27. Presse Med. 2017. PMID: 28457622 French. No abstract available.
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study.
Lemaignen A, Ghout I, Dinh A, Gras G, Fantin B, Zarrouk V, Carlier R, Loret JE, Denes E, Greder A, Lescure FX, Boutoille D, Tattevin P, Issartel B, Cottier JP, Bernard L; DTS (Duration of Treatment for Spondylodiscitis) study group. Lemaignen A, et al. Medicine (Baltimore). 2017 May;96(21):e6387. doi: 10.1097/MD.0000000000006387. Medicine (Baltimore). 2017. PMID: 28538361 Free PMC article. Clinical Trial.
112 results